Patent · US Active

Azalactam compounds as HPK1 inhibitors

US11142525B2 · kind B2 · utility

0Cited by
0References
40Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 11, 2019
Grant dateOct 12, 2021
Priority date
Expiry dateDec 11, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of general Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.